Study guide
10.2 PALICC-2 NIV & Possible PARDS
NBRC RRT-NPS Neonatal/Pediatric Specialist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Neonatal and Pediatric Patient Assessment
1.1 Maternal, Obstetric & Perinatal History 1.2 Fetal Surveillance & Antepartum Diagnostics 1.3 Gestational Age & Baseline Neonatal Examination 1.4 Apgar, Respiratory Distress & Thoracic Assessment 1.5 Pediatric Assessment Triangle & Vital Signs 1.6 Neurologic Assessment, Respiratory Failure & Triage
2 Chapter 2: Diagnostic Evaluation & Gas Exchange Monitoring
2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring 2.2 Capnography, Waveforms & Dead-Space Evaluation 2.3 Arterial & Capillary Blood-Gas Sampling 2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation 2.5 Chest Imaging & Airway Radiography 2.6 Pulmonary Function, Bronchoscopy & Specimen Diagnostics
3 Chapter 3: Airway Management & Secretion Clearance
3.1 Pediatric Airway Anatomy & ETT Sizing 3.2 Cuffed Airways, Intubation & Difficult-Airway Management 3.3 Tracheostomy Devices & Routine Care 3.4 Tracheostomy Emergencies, Speaking & Decannulation 3.5 Airway Suctioning Technique & Safety 3.6 Airway Clearance, Home Care & Discharge Planning
4 Chapter 4: Pharmacology & Medical Gas Therapy
4.1 Aerosol Physics & Delivery Devices 4.2 Respiratory & Systemic Pharmacology 4.3 Oxygen Interfaces & Delivery Systems 4.4 Oxygen Blenders, Targets & Toxicity 4.5 HFNC Physiology, Sizing & Flow 4.6 HFNC Indications, Monitoring & Escalation
5 Chapter 5: Shared Neonatal & Pediatric Pulmonary Disorders
5.1 Neonatal RDS Pathophysiology & Management 5.2 TTN, Pneumonia & the Neonatal Differential 5.3 Meconium Aspiration & PPHN 5.4 BPD, Apnea & Chronic Neonatal Lung Disease 5.5 Bronchiolitis, Croup & Epiglottitis 5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration
6 Chapter 6: Resuscitation, Emergency Protocols & Patient Safety
6.1 NRP Cord Management, Initial Steps & Ventilation 6.2 NRP Corrective Steps, Compressions & Medications 6.3 PALS Assessment, CPR & Cardiac Arrest 6.4 PALS Dysrhythmia & Shock Management 6.5 Neonatal & Pediatric Transport 6.6 Patient Safety, Teamwork & Family-Centered Care
7 Chapter 7: Noninvasive & Conventional Mechanical Ventilation
7.1 Bubble CPAP & Neonatal NIV 7.2 Pediatric NIV, Interfaces & Failure Recognition 7.3 Conventional Ventilation Physics & Modes 7.4 Initial Settings & ABG-Guided Titration 7.5 Ventilator Scalars & Loops 7.6 Ventilator Dyssynchrony & Troubleshooting 7.7 Weaning Readiness & Spontaneous Breathing Trials 7.8 Extubation & Post-Extubation Airway Risk
8 Chapter 8: High-Frequency Ventilation & Advanced Modes
8.1 HFOV Mechanics & Gas Transport 8.2 HFOV Controls & Clinical Management 8.3 HFJV Circuit & Controls 8.4 HFJV Servo Pressure & Clinical Indications 8.5 NAVA, Edi & Proportional Support 8.6 APRV in Pediatric Respiratory Failure
9 Chapter 9: Specialty Inhaled Gases & Exogenous Surfactant Therapy
9.1 Inhaled Nitric Oxide: Mechanism, Indications & Dose 9.2 Inhaled Nitric Oxide: Toxicity, Monitoring & Weaning 9.3 Heliox Physics & Delivery 9.4 Volatile Anesthetic & Subambient Gas Therapy 9.5 Surfactant Biology, Products & Dosing 9.6 Surfactant Administration & Response
10 Chapter 10: Pediatric ARDS & Parenchymal Critical Illness
10.1 PALICC-2 Diagnosis & Severity 10.2 PALICC-2 NIV & Possible PARDS 10.3 PARDS Lung-Protective Ventilation 10.4 PARDS Refractory Hypoxemia & Adjuncts 10.5 PIE & Pneumothorax Recognition 10.6 Thoracic Decompression & Chest Drains
11 Chapter 11: Congenital Heart Disease & Hemodynamic Management
11.1 Left-to-Right Shunts & Qp/Qs Physiology 11.2 Acyanotic Lesions & Respiratory Management 11.3 Cyanotic Lesions & the Five Ts 11.4 Ductal Dependence, PGE1 & the Hyperoxia Test 11.5 Single-Ventricle Physiology & Staged Palliation 11.6 Gas Balancing, Hemodynamics & NIRS
12 Chapter 12: Advanced Critical Care: ECMO, Neurotrauma & Palliative Care
12.1 ECMO Candidacy & Modality 12.2 ECMO Circuit, Lung Rest & Anticoagulation 12.3 Neurotrauma, ICP & Ventilation 12.4 Neonatal Therapeutic Hypothermia & Respiratory Care 12.5 Death by Neurologic Criteria: Examination & Apnea Testing 12.6 DNC Timing, Ancillary Testing, Palliation & Donation
10.2 PALICC-2 NIV & Possible PARDS
Key Takeaways Explain This Topic AI
Full-face CPAP or bilevel support with CPAP at least 5 cm H2O can meet NIV-PARDS criteria; HFNC supports possible PARDS, not NIV-PARDS.
Use P/F or S/F thresholds for noninvasive disease and do not calculate OI from an assumed HFNC airway pressure.
Exclude active perinatal lung disease and apply the age, timing, imaging, risk, and edema-origin requirements before assigning PARDS.
Last updated: September 2026
- 10.2 PALICC-2 NIV & Possible PARDS
- NIV-PARDS
A child on full-face CPAP or bilevel NIV with CPAP of at least 5 cm H2O may meet NIV-PARDS criteria when the timing, risk, imaging, and edema-origin elements are also present. Use PaO2/FiO2 of 300 or less or SpO2/FiO2 of 250 or less for diagnosis.
For NIV-PARDS severity, P/F above 100 or S/F above 150 is mild/moderate; P/F 100 or less or S/F 150 or less is severe. These noninvasive ratios are not interchangeable with OI/OSI because airway pressure is not incorporated the same way.
Possible PARDS on HFNC or an Incomplete Dataset
PALICC-2 recognizes possible PARDS when a patient on nasal respiratory support such as HFNC has the clinical timing, risk factor, imaging, and oxygenation pattern but does not meet the full-face positive-pressure interface requirement. This category promotes recognition and monitoring; it does not justify labeling HFNC as invasive support or calculating OI without an invasively measured mean airway pressure.
An infant must be older than 42 days or have active perinatal lung disease excluded before applying the general PARDS framework. Distinguish acute bronchiolitis without new parenchymal opacities from PARDS triggered by pneumonia or systemic inflammation.
Worked Classification
A ventilated child has MAP 16 cm H2O, FiO2 0.70, and PaO2 68 mmHg. OI = (16 x 0.70 x 100) / 68 = 16.5. If the remaining diagnostic elements are met and the value persists at the severity assessment, this is severe PARDS. The classification increases urgency and monitoring but does not mandate one fixed bundle of rescue therapies.
A child on full-face BiPAP with EPAP 6 cm H2O, new bilateral opacities after pneumonia, and an S/F ratio of 170 may meet mild/moderate NIV-PARDS. A child on HFNC with the same findings is categorized as possible PARDS rather than NIV-PARDS because HFNC is not a full-face CPAP/BiPAP interface.
High-Yield Distinctions
Use OI/OSI for invasive ventilation and P/F or S/F for noninvasive support.
Severity is assessed after at least four hours, not from the first isolated blood gas.
Invasive PALICC-2 categories are mild/moderate versus severe.
Imaging can be unilateral; bilateral infiltrates are not required.
Congenital heart disease does not exclude PARDS when an acute oxygenation decline is not explained by the cardiac lesion.
Noninvasive Support Decision Points
NIV classification does not guarantee that NIV is safe. Confirm an intact airway, manageable secretions, adequate mental status, and hemodynamic stability. Fit the full-face interface while protecting skin and minimizing leak, then reassess respiratory effort, synchrony, oxygen requirement, carbon dioxide, and tolerance. Recurrent apnea, shock, worsening encephalopathy, inability to clear secretions, or progressive acidosis favors intubation.
For example, P/F 90 on full-face bilevel support with EPAP 6 cm H2O meets the severe NIV oxygenation band when the other diagnostic elements are present. The same patient on HFNC belongs in possible PARDS because the interface criterion differs. Neither label should delay airway management.
Documentation checklist
Record the precipitating insult and date, imaging finding, reason edema is not primarily hydrostatic, interface, CPAP or EPAP, FiO2, saturation waveform quality, blood-gas time, and calculated P/F or S/F ratio. State whether the child has congenital heart disease, chronic lung disease, or perinatal lung disease and how the acute change differs from baseline. This makes serial classification reproducible across shifts.
Escalation Example
A child on full-face BiPAP has S/F 140, increasing retractions, drowsiness, and rising carbon dioxide. The ratio meets severe NIV-PARDS, but the examination is more urgent than the label: declining airway protection and ventilation favor controlled intubation. Conversely, a stable child with S/F 180, improving effort, and good synchrony may continue a closely monitored NIV trial. Use the classification to standardize communication while bedside physiology determines the intervention.
Interface distinction
Full-face support matters because it can deliver and measure CPAP more reliably than an open nasal high-flow system. Document actual EPAP or CPAP, leak, synchrony, and patient tolerance. A nasal cannula flow rate cannot be converted into a dependable airway pressure, and changing mouth position can alter pressure unpredictably. Therefore, do not relabel HFNC as CPAP or use a guessed MAP to calculate OI. The interface and measured variables determine which PALICC-2 pathway applies.
Reassess frequently. clinically.